世界のコンパニオンアニマル治療市場 2021：企業別、地域別、種類・用途別

• 英文タイトル：Global Companion Animal Therapeutics Market 2021 by Company, Regions, Type and Application, Forecast to 2026

• レポートコード：GIR-107A12182 • 出版社/出版日：GlobalInfoResearch / 2021年7月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、83ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥522,000 (USD3,480)	▷ お問い合わせ
Multi User	￥783,000 (USD5,220)	▷ お問い合わせ
Corporate User	￥1,044,000 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

当調査資料では、コンパニオンアニマル治療のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。コンパニオンアニマル治療の種類別市場規模（感染症、皮膚病、整形外科、行動障害、その他）、用途別市場規模（犬、猫、馬、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・コンパニオンアニマル治療の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Aratana Therapeutics、Elanco、Boehringer Ingelheim GmbH、Ceva Sante Animale、Dechra Pharmaceuticals、Eli Lilly and Company、Merck、Vetoquinol、Zoetis ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：感染症、皮膚病、整形外科、行動障害、その他 ・用途別分析2016年-2026年：犬、猫、馬、その他 ・コンパニオンアニマル治療の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・コンパニオンアニマル治療のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・コンパニオンアニマル治療のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・コンパニオンアニマル治療の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・コンパニオンアニマル治療の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論

The Companion Animal Therapeutics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Companion Animal Therapeutics size is estimated to be USD xx million in 2026 from USD xx million in 2020, with a change XX% between 2020 and 2021. The global Companion Animal Therapeutics market size is expected to grow at a CAGR of xx% for the next five years.

Market segmentation
Companion Animal Therapeutics market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
Infectious Diseases
Dermatological Diseases
Orthopedic Diseases
Behavioral Disorders
Others

Market segment by Application, can be divided into
Dogs
Cats
Horses
Other

Market segment by players, this report covers
Aratana Therapeutics
Elanco
Boehringer Ingelheim GmbH
Ceva Sante Animale
Dechra Pharmaceuticals
Eli Lilly and Company
Merck
Vetoquinol
Zoetis

Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Companion Animal Therapeutics product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Companion Animal Therapeutics, with revenue, gross margin and global market share of Companion Animal Therapeutics from 2019 to 2021.
Chapter 3, the Companion Animal Therapeutics competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by type and application, with revenue and growth rate by type, application, from 2016 to 2026.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2016 to 2021.and Companion Animal Therapeutics market forecast, by regions, type and application, with revenue, from 2021 to 2026.
Chapter 11 and 12, to describe Companion Animal Therapeutics research findings and conclusion, appendix and data source.

レポート目次

---

1 Market Overview
1.1 Product Overview and Scope of Companion Animal Therapeutics
1.2 Classification of Companion Animal Therapeutics by Type
1.2.1 Overview: Global Companion Animal Therapeutics Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Companion Animal Therapeutics Revenue Market Share by Type in 2020
1.2.3 Infectious Diseases
1.2.4 Dermatological Diseases
1.2.5 Orthopedic Diseases
1.2.6 Behavioral Disorders
1.2.7 Others
1.3 Global Companion Animal Therapeutics Market by Application
1.3.1 Overview: Global Companion Animal Therapeutics Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Dogs
1.3.3 Cats
1.3.4 Horses
1.3.5 Other
1.4 Global Companion Animal Therapeutics Market Size & Forecast
1.5 Global Companion Animal Therapeutics Market Size and Forecast by Region
1.5.1 Global Companion Animal Therapeutics Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Companion Animal Therapeutics Market Size by Region, (2016-2021)
1.5.3 North America Companion Animal Therapeutics Market Size and Prospect (2016-2026)
1.5.4 Europe Companion Animal Therapeutics Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Companion Animal Therapeutics Market Size and Prospect (2016-2026)
1.5.6 South America Companion Animal Therapeutics Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Companion Animal Therapeutics Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Companion Animal Therapeutics Market Drivers
1.6.2 Companion Animal Therapeutics Market Restraints
1.6.3 Companion Animal Therapeutics Trends Analysis
2 Company Profiles
2.1 Aratana Therapeutics
2.1.1 Aratana Therapeutics Details
2.1.2 Aratana Therapeutics Major Business
2.1.3 Aratana Therapeutics Companion Animal Therapeutics Product and Solutions
2.1.4 Aratana Therapeutics Companion Animal Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Aratana Therapeutics Recent Developments and Future Plans
2.2 Elanco
2.2.1 Elanco Details
2.2.2 Elanco Major Business
2.2.3 Elanco Companion Animal Therapeutics Product and Solutions
2.2.4 Elanco Companion Animal Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 Elanco Recent Developments and Future Plans
2.3 Boehringer Ingelheim GmbH
2.3.1 Boehringer Ingelheim GmbH Details
2.3.2 Boehringer Ingelheim GmbH Major Business
2.3.3 Boehringer Ingelheim GmbH Companion Animal Therapeutics Product and Solutions
2.3.4 Boehringer Ingelheim GmbH Companion Animal Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 Boehringer Ingelheim GmbH Recent Developments and Future Plans
2.4 Ceva Sante Animale
2.4.1 Ceva Sante Animale Details
2.4.2 Ceva Sante Animale Major Business
2.4.3 Ceva Sante Animale Companion Animal Therapeutics Product and Solutions
2.4.4 Ceva Sante Animale Companion Animal Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 Ceva Sante Animale Recent Developments and Future Plans
2.5 Dechra Pharmaceuticals
2.5.1 Dechra Pharmaceuticals Details
2.5.2 Dechra Pharmaceuticals Major Business
2.5.3 Dechra Pharmaceuticals Companion Animal Therapeutics Product and Solutions
2.5.4 Dechra Pharmaceuticals Companion Animal Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 Dechra Pharmaceuticals Recent Developments and Future Plans
2.6 Eli Lilly and Company
2.6.1 Eli Lilly and Company Details
2.6.2 Eli Lilly and Company Major Business
2.6.3 Eli Lilly and Company Companion Animal Therapeutics Product and Solutions
2.6.4 Eli Lilly and Company Companion Animal Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 Eli Lilly and Company Recent Developments and Future Plans
2.7 Merck
2.7.1 Merck Details
2.7.2 Merck Major Business
2.7.3 Merck Companion Animal Therapeutics Product and Solutions
2.7.4 Merck Companion Animal Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 Merck Recent Developments and Future Plans
2.8 Vetoquinol
2.8.1 Vetoquinol Details
2.8.2 Vetoquinol Major Business
2.8.3 Vetoquinol Companion Animal Therapeutics Product and Solutions
2.8.4 Vetoquinol Companion Animal Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
2.8.5 Vetoquinol Recent Developments and Future Plans
2.9 Zoetis
2.9.1 Zoetis Details
2.9.2 Zoetis Major Business
2.9.3 Zoetis Companion Animal Therapeutics Product and Solutions
2.9.4 Zoetis Companion Animal Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
2.9.5 Zoetis Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Companion Animal Therapeutics Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 3 Companion Animal Therapeutics Players Market Share
3.2.2 Top 10 Companion Animal Therapeutics Players Market Share
3.2.3 Market Competition Trend
3.3 Companion Animal Therapeutics Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Companion Animal Therapeutics Revenue and Market Share by Type (2016-2021)
4.2 Global Companion Animal Therapeutics Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Companion Animal Therapeutics Revenue Market Share by Application (2016-2021)
5.2 Companion Animal Therapeutics Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Companion Animal Therapeutics Revenue by Type (2016-2026)
6.2 North America Companion Animal Therapeutics Revenue by Application (2016-2026)
6.3 North America Companion Animal Therapeutics Market Size by Country
6.3.1 North America Companion Animal Therapeutics Revenue by Country (2016-2026)
6.3.2 United States Companion Animal Therapeutics Market Size and Forecast (2016-2026)
6.3.3 Canada Companion Animal Therapeutics Market Size and Forecast (2016-2026)
6.3.4 Mexico Companion Animal Therapeutics Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Companion Animal Therapeutics Revenue by Type (2016-2026)
7.2 Europe Companion Animal Therapeutics Revenue by Application (2016-2026)
7.3 Europe Companion Animal Therapeutics Market Size by Country
7.3.1 Europe Companion Animal Therapeutics Revenue by Country (2016-2026)
7.3.2 Germany Companion Animal Therapeutics Market Size and Forecast (2016-2026)
7.3.3 France Companion Animal Therapeutics Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Companion Animal Therapeutics Market Size and Forecast (2016-2026)
7.3.5 Russia Companion Animal Therapeutics Market Size and Forecast (2016-2026)
7.3.6 Italy Companion Animal Therapeutics Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Companion Animal Therapeutics Revenue by Type (2016-2026)
8.2 Asia-Pacific Companion Animal Therapeutics Revenue by Application (2016-2026)
8.3 Asia-Pacific Companion Animal Therapeutics Market Size by Region
8.3.1 Asia-Pacific Companion Animal Therapeutics Revenue by Region (2016-2026)
8.3.2 China Companion Animal Therapeutics Market Size and Forecast (2016-2026)
8.3.3 Japan Companion Animal Therapeutics Market Size and Forecast (2016-2026)
8.3.4 South Korea Companion Animal Therapeutics Market Size and Forecast (2016-2026)
8.3.5 India Companion Animal Therapeutics Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Companion Animal Therapeutics Market Size and Forecast (2016-2026)
8.3.7 Australia Companion Animal Therapeutics Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Companion Animal Therapeutics Revenue by Type (2016-2026)
9.2 South America Companion Animal Therapeutics Revenue by Application (2016-2026)
9.3 South America Companion Animal Therapeutics Market Size by Country
9.3.1 South America Companion Animal Therapeutics Revenue by Country (2016-2026)
9.3.2 Brazil Companion Animal Therapeutics Market Size and Forecast (2016-2026)
9.3.3 Argentina Companion Animal Therapeutics Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Companion Animal Therapeutics Revenue by Type (2016-2026)
10.2 Middle East & Africa Companion Animal Therapeutics Revenue by Application (2016-2026)
10.3 Middle East & Africa Companion Animal Therapeutics Market Size by Country
10.3.1 Middle East & Africa Companion Animal Therapeutics Revenue by Country (2016-2026)
10.3.2 Turkey Companion Animal Therapeutics Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Companion Animal Therapeutics Market Size and Forecast (2016-2026)
10.3.4 UAE Companion Animal Therapeutics Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer

List of Tables
Table 1. Global Companion Animal Therapeutics Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Companion Animal Therapeutics Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Companion Animal Therapeutics Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Companion Animal Therapeutics Revenue (USD Million) by Region (2016-2021)
Table 5. Global Companion Animal Therapeutics Revenue Market Share by Region (2021-2026)
Table 6. Aratana Therapeutics Corporate Information, Head Office, and Major Competitors
Table 7. Aratana Therapeutics Major Business
Table 8. Aratana Therapeutics Companion Animal Therapeutics Product and Solutions
Table 9. Aratana Therapeutics Companion Animal Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. Elanco Corporate Information, Head Office, and Major Competitors
Table 11. Elanco Major Business
Table 12. Elanco Companion Animal Therapeutics Product and Solutions
Table 13. Elanco Companion Animal Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. Boehringer Ingelheim GmbH Corporate Information, Head Office, and Major Competitors
Table 15. Boehringer Ingelheim GmbH Major Business
Table 16. Boehringer Ingelheim GmbH Companion Animal Therapeutics Product and Solutions
Table 17. Boehringer Ingelheim GmbH Companion Animal Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. Ceva Sante Animale Corporate Information, Head Office, and Major Competitors
Table 19. Ceva Sante Animale Major Business
Table 20. Ceva Sante Animale Companion Animal Therapeutics Product and Solutions
Table 21. Ceva Sante Animale Companion Animal Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. Dechra Pharmaceuticals Corporate Information, Head Office, and Major Competitors
Table 23. Dechra Pharmaceuticals Major Business
Table 24. Dechra Pharmaceuticals Companion Animal Therapeutics Product and Solutions
Table 25. Dechra Pharmaceuticals Companion Animal Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. Eli Lilly and Company Corporate Information, Head Office, and Major Competitors
Table 27. Eli Lilly and Company Major Business
Table 28. Eli Lilly and Company Companion Animal Therapeutics Product and Solutions
Table 29. Eli Lilly and Company Companion Animal Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. Merck Corporate Information, Head Office, and Major Competitors
Table 31. Merck Major Business
Table 32. Merck Companion Animal Therapeutics Product and Solutions
Table 33. Merck Companion Animal Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 34. Vetoquinol Corporate Information, Head Office, and Major Competitors
Table 35. Vetoquinol Major Business
Table 36. Vetoquinol Companion Animal Therapeutics Product and Solutions
Table 37. Vetoquinol Companion Animal Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 38. Zoetis Corporate Information, Head Office, and Major Competitors
Table 39. Zoetis Major Business
Table 40. Zoetis Companion Animal Therapeutics Product and Solutions
Table 41. Zoetis Companion Animal Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 42. Global Companion Animal Therapeutics Revenue (USD Million) by Players (2019-2021)
Table 43. Global Companion Animal Therapeutics Revenue Share by Players (2019-2021)
Table 44. Breakdown of Companion Animal Therapeutics by Company Type (Tier 1, Tier 2 and Tier 3)
Table 45. Companion Animal Therapeutics Players Head Office, Products and Services Provided
Table 46. Companion Animal Therapeutics Mergers & Acquisitions in the Past Five Years
Table 47. Companion Animal Therapeutics New Entrants and Expansion Plans
Table 48. Global Companion Animal Therapeutics Revenue (USD Million) by Type (2016-2021)
Table 49. Global Companion Animal Therapeutics Revenue Share by Type (2016-2021)
Table 50. Global Companion Animal Therapeutics Revenue Forecast by Type (2021-2026)
Table 51. Global Companion Animal Therapeutics Revenue by Application (2016-2021)
Table 52. Global Companion Animal Therapeutics Revenue Forecast by Application (2021-2026)
Table 53. North America Companion Animal Therapeutics Revenue by Type (2016-2021) & (USD Million)
Table 54. North America Companion Animal Therapeutics Revenue by Type (2021-2026) & (USD Million)
Table 55. North America Companion Animal Therapeutics Revenue by Application (2016-2021) & (USD Million)
Table 56. North America Companion Animal Therapeutics Revenue by Application (2021-2026) & (USD Million)
Table 57. North America Companion Animal Therapeutics Revenue by Country (2016-2021) & (USD Million)
Table 58. North America Companion Animal Therapeutics Revenue by Country (2021-2026) & (USD Million)
Table 59. Europe Companion Animal Therapeutics Revenue by Type (2016-2021) & (USD Million)
Table 60. Europe Companion Animal Therapeutics Revenue by Type (2021-2026) & (USD Million)
Table 61. Europe Companion Animal Therapeutics Revenue by Application (2016-2021) & (USD Million)
Table 62. Europe Companion Animal Therapeutics Revenue by Application (2021-2026) & (USD Million)
Table 63. Europe Companion Animal Therapeutics Revenue by Country (2016-2021) & (USD Million)
Table 64. Europe Companion Animal Therapeutics Revenue by Country (2021-2026) & (USD Million)
Table 65. Asia-Pacific Companion Animal Therapeutics Revenue by Type (2016-2021) & (USD Million)
Table 66. Asia-Pacific Companion Animal Therapeutics Revenue by Type (2021-2026) & (USD Million)
Table 67. Asia-Pacific Companion Animal Therapeutics Revenue by Application (2016-2021) & (USD Million)
Table 68. Asia-Pacific Companion Animal Therapeutics Revenue by Application (2021-2026) & (USD Million)
Table 69. Asia-Pacific Companion Animal Therapeutics Revenue by Region (2016-2021) & (USD Million)
Table 70. Asia-Pacific Companion Animal Therapeutics Revenue by Region (2021-2026) & (USD Million)
Table 71. South America Companion Animal Therapeutics Revenue by Type (2016-2021) & (USD Million)
Table 72. South America Companion Animal Therapeutics Revenue by Type (2021-2026) & (USD Million)
Table 73. South America Companion Animal Therapeutics Revenue by Application (2016-2021) & (USD Million)
Table 74. South America Companion Animal Therapeutics Revenue by Application (2021-2026) & (USD Million)
Table 75. South America Companion Animal Therapeutics Revenue by Country (2016-2021) & (USD Million)
Table 76. South America Companion Animal Therapeutics Revenue by Country (2021-2026) & (USD Million)
Table 77. Middle East & Africa Companion Animal Therapeutics Revenue by Type (2016-2021) & (USD Million)
Table 78. Middle East & Africa Companion Animal Therapeutics Revenue by Type (2021-2026) & (USD Million)
Table 79. Middle East & Africa Companion Animal Therapeutics Revenue by Application (2016-2021) & (USD Million)
Table 80. Middle East & Africa Companion Animal Therapeutics Revenue by Application (2021-2026) & (USD Million)
Table 81. Middle East & Africa Companion Animal Therapeutics Revenue by Country (2016-2021) & (USD Million)
Table 82. Middle East & Africa Companion Animal Therapeutics Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Companion Animal Therapeutics Picture
Figure 2. Global Companion Animal Therapeutics Revenue Market Share by Type in 2020
Figure 3. Infectious Diseases
Figure 4. Dermatological Diseases
Figure 5. Orthopedic Diseases
Figure 6. Behavioral Disorders
Figure 7. Others
Figure 8. Companion Animal Therapeutics Revenue Market Share by Application in 2020
Figure 9. Dogs Picture
Figure 10. Cats Picture
Figure 11. Horses Picture
Figure 12. Other Picture
Figure 13. Global Companion Animal Therapeutics Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 14. Global Companion Animal Therapeutics Revenue and Forecast (2016-2026) & (USD Million)
Figure 15. Global Companion Animal Therapeutics Revenue Market Share by Region (2016-2026)
Figure 16. Global Companion Animal Therapeutics Revenue Market Share by Region in 2020
Figure 17. North America Companion Animal Therapeutics Revenue (USD Million) and Growth Rate (2016-2026)
Figure 18. Europe Companion Animal Therapeutics Revenue (USD Million) and Growth Rate (2016-2026)
Figure 19. Asia-Pacific Companion Animal Therapeutics Revenue (USD Million) and Growth Rate (2016-2026)
Figure 20. South America Companion Animal Therapeutics Revenue (USD Million) and Growth Rate (2016-2026)
Figure 21. Middle East and Africa Companion Animal Therapeutics Revenue (USD Million) and Growth Rate (2016-2026)
Figure 22. Companion Animal Therapeutics Market Drivers
Figure 23. Companion Animal Therapeutics Market Restraints
Figure 24. Companion Animal Therapeutics Market Trends
Figure 25. Aratana Therapeutics Recent Developments and Future Plans
Figure 26. Elanco Recent Developments and Future Plans
Figure 27. Boehringer Ingelheim GmbH Recent Developments and Future Plans
Figure 28. Ceva Sante Animale Recent Developments and Future Plans
Figure 29. Dechra Pharmaceuticals Recent Developments and Future Plans
Figure 30. Eli Lilly and Company Recent Developments and Future Plans
Figure 31. Merck Recent Developments and Future Plans
Figure 32. Vetoquinol Recent Developments and Future Plans
Figure 33. Zoetis Recent Developments and Future Plans
Figure 34. Global Companion Animal Therapeutics Revenue Share by Players in 2020
Figure 35. Companion Animal Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 36. Global Top 3 Players Companion Animal Therapeutics Revenue Market Share in 2020
Figure 37. Global Top 10 Players Companion Animal Therapeutics Revenue Market Share in 2020
Figure 38. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 39. Global Companion Animal Therapeutics Revenue Share by Type in 2020
Figure 40. Global Companion Animal Therapeutics Market Share Forecast by Type (2021-2026)
Figure 41. Global Companion Animal Therapeutics Revenue Share by Application in 2020
Figure 42. Global Companion Animal Therapeutics Market Share Forecast by Application (2021-2026)
Figure 43. North America Companion Animal Therapeutics Sales Market Share by Type (2016-2026)
Figure 44. North America Companion Animal Therapeutics Sales Market Share by Application (2016-2026)
Figure 45. North America Companion Animal Therapeutics Revenue Market Share by Country (2016-2026)
Figure 46. United States Companion Animal Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 47. Canada Companion Animal Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 48. Mexico Companion Animal Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 49. Europe Companion Animal Therapeutics Sales Market Share by Type (2016-2026)
Figure 50. Europe Companion Animal Therapeutics Sales Market Share by Application (2016-2026)
Figure 51. Europe Companion Animal Therapeutics Revenue Market Share by Country (2016-2026)
Figure 52. Germany Companion Animal Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. France Companion Animal Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. United Kingdom Companion Animal Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. Russia Companion Animal Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. Italy Companion Animal Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. Asia-Pacific Companion Animal Therapeutics Sales Market Share by Type (2016-2026)
Figure 58. Asia-Pacific Companion Animal Therapeutics Sales Market Share by Application (2016-2026)
Figure 59. Asia-Pacific Companion Animal Therapeutics Revenue Market Share by Region (2016-2026)
Figure 60. China Companion Animal Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. Japan Companion Animal Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. South Korea Companion Animal Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. India Companion Animal Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. Southeast Asia Companion Animal Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 65. Australia Companion Animal Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 66. South America Companion Animal Therapeutics Sales Market Share by Type (2016-2026)
Figure 67. South America Companion Animal Therapeutics Sales Market Share by Application (2016-2026)
Figure 68. South America Companion Animal Therapeutics Revenue Market Share by Country (2016-2026)
Figure 69. Brazil Companion Animal Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 70. Argentina Companion Animal Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 71. Middle East and Africa Companion Animal Therapeutics Sales Market Share by Type (2016-2026)
Figure 72. Middle East and Africa Companion Animal Therapeutics Sales Market Share by Application (2016-2026)
Figure 73. Middle East and Africa Companion Animal Therapeutics Revenue Market Share by Country (2016-2026)
Figure 74. Turkey Companion Animal Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 75. Saudi Arabia Companion Animal Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 76. UAE Companion Animal Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 77. Methodology
Figure 78. Research Process and Data Source

---